Biotechnology
The Biotechnology industry has a total of 590 stocks, with a combined market cap of $1.15 trillion and total revenue of $111.28 billion.
Market Cap
1.15T
Revenue
111.28B
Profits
-41.54B
PE Ratio
n/a
Profit Margin
-37.33%
Dividend Yield
0.04%
590 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 115.45B | 0.40% | 311,463 | 12.22B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 73.23B | -0.01% | 193,277 | 14.92B |
| 3 | ARGX | argenx SE | 50.04B | 1.31% | 81,341 | 4.74B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 39.21B | 0.75% | 259,893 | 4.29B |
| 5 | ONC | BeOne Medicines AG | 33.69B | -4.27% | 72,405 | 5.70B |
| 6 | RVMD | Revolution Medicines, Inc. | 31.52B | -1.12% | 431,164 | - |
| 7 | RPRX | Royalty Pharma plc | 30.50B | -0.53% | 1,327,897 | 2.44B |
| 8 | INSM | Insmed Incorporated | 25.46B | -0.45% | 843,739 | 819.56M |
| 9 | BNTX | BioNTech SE | 23.34B | 0.05% | 217,980 | 3.23B |
| 10 | ROIV | Roivant Sciences Ltd. | 21.11B | 0.92% | 825,714 | 13.31M |
| 11 | MRNA | Moderna, Inc. | 20.09B | 0.42% | 2,233,592 | 2.23B |
| 12 | INCY | Incyte Corporation | 19.60B | -0.74% | 362,540 | 5.36B |
| 13 | GMAB | Genmab A/S | 16.20B | 2.13% | 591,182 | 3.90B |
| 14 | ASND | Ascendis Pharma A/S | 15.15B | 0.16% | 59,563 | 998.25M |
| 15 | JAZZ | Jazz Pharmaceuticals plc | 14.48B | -0.65% | 205,842 | 4.44B |
| 16 | SMMT | Summit Therapeutics Inc. | 14.09B | -3.41% | 754,696 | - |
| 17 | BBIO | BridgeBio Pharma, Inc. | 13.52B | 0.63% | 628,083 | 579.96M |
| 18 | EXEL | Exelixis, Inc. | 12.91B | 0.14% | 824,461 | 2.38B |
| 19 | IONS | Ionis Pharmaceuticals, Inc. | 12.54B | -2.20% | 555,693 | 1.06B |
| 20 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.38B | 3.52% | 87,618 | 1.13B |
| 21 | AXSM | Axsome Therapeutics, Inc. | 11.93B | -1.46% | 137,426 | 708.24M |
| 22 | ARWR | Arrowhead Pharmaceuticals, Inc. | 11.15B | 1.67% | 892,911 | 622.01M |
| 23 | BMRN | BioMarin Pharmaceutical Inc. | 10.31B | -0.34% | 300,536 | 3.24B |
| 24 | ABVX | ABIVAX Société Anonyme | 9.73B | -0.64% | 311,798 | 5.37M |
| 25 | CYTK | Cytokinetics, Incorporated | 9.64B | 0.34% | 661,978 | 105.82M |
| 26 | PRAX | Praxis Precision Medicines, Inc. | 9.56B | -1.16% | 91,180 | 7.46M |
| 27 | KRYS | Krystal Biotech, Inc. | 9.24B | 0.30% | 216,133 | 417.30M |
| 28 | IBRX | ImmunityBio, Inc. | 8.55B | 0.12% | 3,955,777 | 140.98M |
| 29 | NUVL | Nuvalent, Inc. | 8.31B | -0.07% | 102,913 | - |
| 30 | HALO | Halozyme Therapeutics, Inc. | 8.19B | -1.36% | 422,170 | 1.51B |
| 31 | PCVX | Vaxcyte, Inc. | 7.82B | -0.22% | 386,681 | - |
| 32 | TECH | Bio-Techne Corporation | 7.08B | 0.78% | 1,299,822 | 1.21B |
| 33 | KYMR | Kymera Therapeutics, Inc. | 6.96B | -1.13% | 93,256 | 51.48M |
| 34 | MIRM | Mirum Pharmaceuticals, Inc. | 6.77B | 1.69% | 339,103 | 569.61M |
| 35 | PTGX | Protagonist Therapeutics, Inc. | 6.70B | 0.25% | 88,601 | 74.06M |
| 36 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.54B | 1.87% | 150,150 | 217.17M |
| 37 | SYRE | Spyre Therapeutics, Inc. | 6.52B | -1.55% | 105,898 | - |
| 38 | CELC | Celcuity Inc. | 6.47B | 7.54% | 879,355 | - |
| 39 | CORT | Corcept Therapeutics Incorporated | 6.30B | 2.80% | 630,604 | 769.10M |
| 40 | APGE | Apogee Therapeutics, Inc. | 6.22B | -1.13% | 170,474 | - |
| 41 | CGON | CG Oncology, Inc. | 6.18B | -5.36% | 336,509 | 5.07M |
| 42 | CNTA | Centessa Pharmaceuticals plc | 6.13B | 0.04% | 741,651 | 15.00M |
| 43 | PTCT | PTC Therapeutics, Inc. | 6.07B | -0.44% | 154,203 | 827.11M |
| 44 | SRRK | Scholar Rock Holding Corporation | 6.00B | -0.16% | 505,929 | - |
| 45 | BLTE | Belite Bio, Inc | 5.95B | -1.51% | 78,718 | - |
| 46 | TGTX | TG Therapeutics, Inc. | 5.91B | -2.25% | 533,934 | 700.35M |
| 47 | IMVT | Immunovant, Inc. | 5.90B | -0.85% | 168,771 | - |
| 48 | COGT | Cogent Biosciences, Inc. | 5.90B | 0.67% | 343,964 | - |
| 49 | XENE | Xenon Pharmaceuticals Inc. | 5.37B | -0.63% | 208,523 | 7.50M |
| 50 | LEGN | Legend Biotech Corporation | 5.31B | 0.17% | 941,322 | 1.14B |
| 51 | APLS | Apellis Pharmaceuticals, Inc. | 5.25B | - | - | 1.11B |
| 52 | CRSP | CRISPR Therapeutics AG | 4.89B | -3.98% | 761,706 | 4.10M |
| 53 | DNTH | Dianthus Therapeutics, Inc. | 4.65B | -0.71% | 60,441 | 1.34M |
| 54 | MANE | Veradermics, Incorporated | 4.43B | 0.34% | 92,811 | - |
| 55 | LGND | Ligand Pharmaceuticals Incorporated | 4.39B | -0.95% | 48,707 | 274.48M |
| 56 | NAMS | NewAmsterdam Pharma Company N.V. | 4.31B | -0.79% | 237,752 | 22.57M |
| 57 | CAI | Caris Life Sciences, Inc. | 4.21B | 1.50% | 897,536 | 907.29M |
| 58 | TVTX | Travere Therapeutics, Inc. | 4.08B | -1.62% | 653,624 | 536.20M |
| 59 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.97B | 0.48% | 277,911 | 18.07M |
| 60 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.81B | 0.03% | 1,321,144 | 596.96M |
| 61 | ACAD | ACADIA Pharmaceuticals Inc. | 3.80B | 0.05% | 416,503 | 1.10B |
| 62 | ORKA | Oruka Therapeutics, Inc. | 3.79B | -0.57% | 575,470 | - |
| 63 | VKTX | Viking Therapeutics, Inc. | 3.66B | -0.47% | 582,340 | - |
| 64 | TLX | Telix Pharmaceuticals Limited | 3.66B | 3.04% | 60,086 | 803.79M |
| 65 | EWTX | Edgewise Therapeutics, Inc. | 3.56B | -2.07% | 185,114 | - |
| 66 | TNGX | Tango Therapeutics, Inc. | 3.33B | -9.84% | 2,120,786 | 56.99M |
| 67 | ERAS | Erasca, Inc. | 3.22B | -0.96% | 1,317,540 | - |
| 68 | RCUS | Arcus Biosciences, Inc. | 3.15B | 0.20% | 176,912 | 236.00M |
| 69 | DNLI | Denali Therapeutics Inc. | 3.09B | -1.52% | 586,642 | - |
| 70 | ALMS | Alumis Inc. | 3.06B | -3.18% | 211,877 | 24.05M |
| 71 | DYN | Dyne Therapeutics, Inc. | 3.02B | -1.08% | 213,215 | - |
| 72 | BEAM | Beam Therapeutics Inc. | 2.95B | -6.88% | 1,023,181 | 164.01M |
| 73 | VERA | Vera Therapeutics, Inc. | 2.86B | 1.66% | 271,052 | - |
| 74 | KLRA | Kailera Therapeutics, Inc. | 2.79B | 1.94% | 107,154 | - |
| 75 | SLNO | Soleno Therapeutics, Inc. | 2.76B | 0.07% | 587,544 | 285.01M |
| 76 | TARS | Tarsus Pharmaceuticals, Inc. | 2.76B | -0.88% | 121,651 | 535.08M |
| 77 | ARQT | Arcutis Biotherapeutics, Inc. | 2.75B | 1.43% | 579,849 | 415.62M |
| 78 | GPCR | Structure Therapeutics Inc. | 2.69B | -0.50% | 195,839 | - |
| 79 | IRON | Disc Medicine, Inc. | 2.64B | -1.37% | 191,793 | - |
| 80 | ELVN | Enliven Therapeutics, Inc. | 2.59B | -2.39% | 224,352 | - |
| 81 | RARE | Ultragenyx Pharmaceutical Inc. | 2.57B | -0.91% | 354,624 | 670.00M |
| 82 | CLDX | Celldex Therapeutics, Inc. | 2.56B | 0.15% | 110,987 | 865.00K |
| 83 | IDYA | IDEAYA Biosciences, Inc. | 2.55B | 0.28% | 204,305 | 225.27M |
| 84 | IMNM | Immunome, Inc. | 2.53B | 0.50% | 175,731 | 4.02M |
| 85 | NKTR | Nektar Therapeutics | 2.51B | -2.21% | 260,831 | 55.63M |
| 86 | NBTX | Nanobiotix S.A. | 2.50B | 3.77% | 107,659 | 38.27M |
| 87 | RLAY | Relay Therapeutics, Inc. | 2.47B | -2.65% | 1,929,110 | 10.68M |
| 88 | KOD | Kodiak Sciences Inc. | 2.43B | -1.77% | 153,623 | - |
| 89 | DFTX | Definium Therapeutics, Inc. | 2.37B | -1.09% | 352,144 | - |
| 90 | ZLAB | Zai Lab Limited | 2.24B | -2.49% | 415,091 | 453.28M |
| 91 | MLYS | Mineralys Therapeutics, Inc. | 2.21B | -0.22% | 176,181 | - |
| 92 | TYRA | Tyra Biosciences, Inc. | 2.16B | 0.22% | 158,105 | - |
| 93 | PHVS | Pharvaris N.V. | 2.11B | -2.06% | 56,424 | - |
| 94 | TRVI | Trevi Therapeutics, Inc. | 2.11B | -2.88% | 228,295 | - |
| 95 | OCUL | Ocular Therapeutix, Inc. | 2.06B | 1.84% | 579,897 | 52.04M |
| 96 | AUPH | Aurinia Pharmaceuticals Inc. | 2.05B | -0.62% | 358,801 | 298.30M |
| 97 | GENB | Generate Biomedicines, Inc. | 2.04B | -1.36% | 149,082 | 30.30M |
| 98 | SRPT | Sarepta Therapeutics, Inc. | 2.02B | 1.43% | 652,912 | 2.18B |
| 99 | ADMA | ADMA Biologics, Inc. | 1.99B | 1.18% | 1,167,373 | 509.86M |
| 100 | SION | Sionna Therapeutics, Inc. | 1.98B | 1.80% | 95,799 | - |
| 101 | MESO | Mesoblast Limited | 1.93B | 1.90% | 57,454 | 65.38M |
| 102 | STOK | Stoke Therapeutics, Inc. | 1.92B | -2.90% | 146,990 | 32.08M |
| 103 | NTLA | Intellia Therapeutics, Inc. | 1.89B | -5.32% | 4,499,953 | 66.09M |
| 104 | AAPG | Ascentage Pharma Group International | 1.88B | -6.01% | 6,028 | 82.08M |
| 105 | LKFT | Lakefront Biotherapeutics NV | 1.86B | -2.13% | 55,445 | 1.20B |
| 106 | SNDX | Syndax Pharmaceuticals, Inc. | 1.85B | 0.05% | 358,841 | 217.17M |
| 107 | TSHA | Taysha Gene Therapies, Inc. | 1.84B | -4.20% | 583,475 | 7.47M |
| 108 | VRDN | Viridian Therapeutics, Inc. | 1.83B | 3.99% | 621,748 | 70.92M |
| 109 | RAPP | Rapport Therapeutics, Inc. | 1.82B | -0.18% | 53,169 | 20.00M |
| 110 | ANAB | AnaptysBio, Inc. | 1.81B | -0.76% | 164,207 | 232.39M |
| 111 | HRMY | Harmony Biosciences Holdings, Inc. | 1.81B | 1.23% | 106,298 | 899.11M |
| 112 | OCS | Oculis Holding AG | 1.80B | -3.22% | 144,055 | 1.40M |
| 113 | MBX | MBX Biosciences, Inc. | 1.77B | -0.72% | 104,973 | - |
| 114 | CAPR | Capricor Therapeutics, Inc. | 1.75B | -0.59% | 388,089 | 11.13M |
| 115 | QURE | uniQure N.V. | 1.73B | -6.00% | 547,938 | 18.09M |
| 116 | ZYME | Zymeworks Inc. | 1.73B | -3.66% | 117,857 | 81.26M |
| 117 | PVLA | Palvella Therapeutics, Inc. | 1.72B | -0.42% | 43,368 | - |
| 118 | PGEN | Precigen, Inc. | 1.72B | 16.02% | 5,798,538 | 31.60M |
| 119 | AGIO | Agios Pharmaceuticals, Inc. | 1.72B | 0.28% | 126,295 | 66.05M |
| 120 | INVA | Innoviva, Inc. | 1.70B | -0.30% | 168,897 | 420.69M |
| 121 | INBX | Inhibrx Biosciences, Inc. | 1.69B | -1.98% | 140,657 | 1.30M |
| 122 | VCEL | Vericel Corporation | 1.68B | 0.15% | 86,359 | 292.09M |
| 123 | NRIX | Nurix Therapeutics, Inc. | 1.66B | -0.68% | 137,966 | 71.78M |
| 124 | RXRX | Recursion Pharmaceuticals, Inc. | 1.66B | 2.62% | 6,687,268 | 66.41M |
| 125 | NUVB | Nuvation Bio Inc. | 1.66B | -0.21% | 1,231,510 | 143.05M |
| 126 | IOVA | Iovance Biotherapeutics, Inc. | 1.61B | -1.78% | 5,678,409 | 285.61M |
| 127 | ARDX | Ardelyx, Inc. | 1.59B | 0.78% | 590,450 | 427.68M |
| 128 | GLUE | Monte Rosa Therapeutics, Inc. | 1.59B | -1.00% | 111,197 | 42.95M |
| 129 | VIR | Vir Biotechnology, Inc. | 1.53B | -2.79% | 482,024 | 65.50M |
| 130 | ATAI | AtaiBeckley Inc. | 1.50B | -3.77% | 1,224,464 | 3.49M |
| 131 | IMTX | Immatics N.V. | 1.49B | 3.15% | 143,483 | 43.00M |
| 132 | NVAX | Novavax, Inc. | 1.49B | -1.84% | 1,960,199 | 596.34M |
| 133 | IMCR | Immunocore Holdings plc | 1.46B | -0.73% | 28,867 | 412.81M |
| 134 | MAZE | Maze Therapeutics, Inc. | 1.46B | -2.49% | 92,026 | 20.00M |
| 135 | DMRA | Damora Therapeutics, Inc. | 1.43B | -1.66% | 50,024 | - |
| 136 | URGN | UroGen Pharma Ltd. | 1.43B | -5.40% | 323,193 | 140.49M |
| 137 | KALV | KalVista Pharmaceuticals, Inc. | 1.42B | -0.09% | 1,749,956 | 73.62M |
| 138 | ABCL | AbCellera Biologics Inc. | 1.42B | -2.31% | 2,912,680 | 79.21M |
| 139 | FTRE | Fortrea Holdings Inc. | 1.39B | 1.80% | 212,280 | 2.71B |
| 140 | BHVN | Biohaven Ltd. | 1.39B | 2.21% | 551,859 | - |
| 141 | SVRA | Savara Inc. | 1.37B | 2.47% | 364,251 | - |
| 142 | GHRS | GH Research PLC | 1.35B | -0.57% | 51,505 | - |
| 143 | AVBP | ArriVent BioPharma, Inc. | 1.35B | -0.07% | 60,809 | - |
| 144 | MPLT | MapLight Therapeutics, Inc. | 1.34B | -3.42% | 50,773 | - |
| 145 | WVE | Wave Life Sciences Ltd. | 1.33B | -1.00% | 1,236,964 | 71.80M |
| 146 | MLTX | MoonLake Immunotherapeutics | 1.33B | -0.76% | 201,213 | - |
| 147 | BCAX | Bicara Therapeutics Inc. | 1.32B | -4.00% | 375,730 | - |
| 148 | SLS | SELLAS Life Sciences Group, Inc. | 1.32B | 8.42% | 6,753,665 | - |
| 149 | AVLN | Avalyn Pharma Inc. | 1.30B | 0.55% | 57,638 | - |
| 150 | COAG | Hemab Therapeutics Holdings, Inc. | 1.29B | 2.42% | 31,835 | - |
| 151 | OLMA | Olema Pharmaceuticals, Inc. | 1.23B | 3.31% | 283,802 | - |
| 152 | ZBIO | Zenas BioPharma, Inc. | 1.21B | -3.91% | 129,671 | 10.00M |
| 153 | JBIO | Jade Biosciences, Inc. | 1.21B | -2.31% | 31,848 | - |
| 154 | SEPN | Septerna, Inc. | 1.19B | 7.07% | 116,427 | 72.26M |
| 155 | DBVT | DBV Technologies S.A. | 1.17B | 0.61% | 117,333 | 5.74M |
| 156 | IVA | Inventiva S.A. | 1.16B | 1.17% | 69,244 | 7.94M |
| 157 | CRVS | Corvus Pharmaceuticals, Inc. | 1.16B | -13.07% | 1,845,486 | - |
| 158 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.13B | - | 686,068 | 204.73M |
| 159 | EYPT | EyePoint, Inc. | 1.11B | -1.12% | 152,809 | 7.61M |
| 160 | AKTS | Aktis Oncology, Inc. | 1.09B | 1.15% | 35,558 | 8.28M |
| 161 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.05B | -2.87% | 1,182,071 | 69.64M |
| 162 | CGEM | Cullinan Therapeutics, Inc. | 1.01B | 0.18% | 218,820 | - |
| 163 | PHAT | Phathom Pharmaceuticals, Inc. | 1.01B | 0.76% | 315,435 | 204.89M |
| 164 | MNKD | MannKind Corporation | 988.64M | -0.31% | 1,396,637 | 360.78M |
| 165 | OMER | Omeros Corporation | 962.59M | -7.51% | 1,644,661 | 9.89M |
| 166 | PHAR | Pharming Group N.V. | 940.29M | -0.77% | 8,728 | 369.49M |
| 167 | LBRX | LB Pharmaceuticals Inc | 918.94M | -0.82% | 13,507 | - |
| 168 | DSGN | Design Therapeutics, Inc. | 914.99M | -6.21% | 81,718 | - |
| 169 | DRTS | Alpha Tau Medical Ltd. | 908.26M | 7.05% | 397,033 | - |
| 170 | MGTX | MeiraGTx Holdings plc | 908.15M | -1.60% | 140,025 | 79.76M |
| 171 | GERN | Geron Corporation | 907.75M | 0.35% | 7,012,983 | 196.12M |
| 172 | SPTX | Seaport Therapeutics, Inc. | 905.59M | 3.50% | 170,454 | - |
| 173 | JANX | Janux Therapeutics, Inc. | 886.10M | -0.55% | 185,974 | 13.73M |
| 174 | XNCR | Xencor, Inc. | 885.99M | -3.47% | 142,701 | 97.36M |
| 175 | ANNX | Annexon, Inc. | 881.47M | -1.28% | 396,693 | - |
| 176 | ORIC | ORIC Pharmaceuticals, Inc. | 880.93M | -1.05% | 223,516 | - |
| 177 | SANA | Sana Biotechnology, Inc. | 879.40M | -1.25% | 20,906,271 | - |
| 178 | ABSI | Absci Corporation | 873.07M | 5.66% | 2,537,957 | 1.84M |
| 179 | KURA | Kura Oncology, Inc. | 866.44M | 2.95% | 604,459 | 71.64M |
| 180 | TBPH | Theravance Biopharma, Inc. | 852.17M | -0.84% | 70,799 | 109.78M |
| 181 | ABUS | Arbutus Biopharma Corporation | 844.47M | -0.81% | 223,710 | 191.45M |
| 182 | ODTX | Odyssey Therapeutics, Inc. | 843.47M | -0.33% | 75,600 | 2.98M |
| 183 | EVMN | Evommune, Inc. | 833.83M | -0.60% | 122,711 | 10.00M |
| 184 | AURA | Aura Biosciences, Inc. | 831.23M | 0.25% | 132,098 | - |
| 185 | DRUG | Bright Minds Biosciences Inc. | 830.81M | -1.64% | 98,212 | - |
| 186 | SPRY | ARS Pharmaceuticals, Inc. | 827.17M | 4.00% | 631,689 | 84.28M |
| 187 | VOR | Vor Biopharma Inc. | 823.08M | -4.53% | 566,456 | - |
| 188 | CTMX | CytomX Therapeutics, Inc. | 820.74M | -0.53% | 929,145 | 35.54M |
| 189 | SGP | SpyGlass Pharma, Inc. | 808.92M | 1.60% | 13,113 | - |
| 190 | ANRO | Alto Neuroscience, Inc. | 790.79M | -1.27% | 225,684 | - |
| 191 | RLMD | Relmada Therapeutics, Inc. | 775.12M | -1.34% | 94,853 | - |
| 192 | SLDB | Solid Biosciences Inc. | 763.97M | 5.15% | 836,366 | - |
| 193 | ALLO | Allogene Therapeutics, Inc. | 762.79M | -5.15% | 5,127,816 | 22.00K |
| 194 | TENX | Tenax Therapeutics, Inc. | 709.48M | 1.18% | 120,726 | - |
| 195 | ZVRA | Zevra Therapeutics, Inc. | 707.61M | 7.64% | 1,594,266 | 122.29M |
| 196 | EIKN | Eikon Therapeutics, Inc. | 692.43M | 3.90% | 158,013 | - |
| 197 | ACRS | Aclaris Therapeutics, Inc. | 682.96M | -3.93% | 1,011,586 | 8.37M |
| 198 | CBIO | Crescent Biopharma, Inc. | 674.88M | 3.57% | 41,647 | 11.88M |
| 199 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 661.07M | 2.23% | 130,150 | - |
| 200 | STRO | Sutro Biopharma, Inc. | 654.43M | -0.25% | 43,463 | 102.48M |
| 201 | KYTX | Kyverna Therapeutics, Inc. | 651.91M | -0.09% | 477,473 | - |
| 202 | CADL | Candel Therapeutics, Inc. | 644.78M | -1.57% | 1,372,714 | - |
| 203 | FBRX | Forte Biosciences, Inc. | 632.39M | 1.12% | 9,332 | - |
| 204 | CRMD | CorMedix Inc. | 626.75M | 6.53% | 2,941,603 | 400.05M |
| 205 | GYRE | Gyre Therapeutics, Inc. | 621.33M | -6.59% | 162,393 | 117.05M |
| 206 | TRAX | First Tracks Biotherapeutics, Inc. | 619.57M | -3.26% | 66,845 | - |
| 207 | ARVN | Arvinas, Inc. | 614.24M | -3.55% | 345,619 | 89.40M |
| 208 | RIGL | Rigel Pharmaceuticals, Inc. | 591.14M | -0.56% | 212,905 | 299.77M |
| 209 | CABA | Cabaletta Bio, Inc. | 585.35M | - | 1,769,940 | - |
| 210 | ALT | Altimmune, Inc. | 581.48M | -0.99% | 918,934 | 36.00K |
| 211 | PRME | Prime Medicine, Inc. | 572.56M | -3.06% | 927,086 | 4.03M |
| 212 | VALN | Valneva SE | 572.49M | -0.77% | 22,030 | 205.07M |
| 213 | ANL | Adlai Nortye Ltd. | 566.41M | 1.58% | 82,603 | 5.00M |
| 214 | IMMX | Immix Biopharma, Inc. | 555.04M | -0.19% | 226,059 | - |
| 215 | TECX | Tectonic Therapeutic, Inc. | 554.85M | 2.07% | 34,811 | - |
| 216 | AGMB | AgomAb Therapeutics NV | 545.18M | -0.98% | 78,907 | - |
| 217 | CLYM | Climb Bio, Inc. | 545.04M | - | 116,678 | - |
| 218 | DNA | Ginkgo Bioworks Holdings, Inc. | 538.93M | -3.96% | 279,648 | 151.40M |
| 219 | MDXG | MiMedx Group, Inc. | 531.74M | 1.42% | 340,560 | 389.42M |
| 220 | XOMA | XOMA Royalty Corporation | 527.16M | 0.56% | 117,721 | 48.56M |
| 221 | CTNM | Contineum Therapeutics, Inc. | 526.77M | -0.42% | 22,213 | - |
| 222 | FDMT | 4D Molecular Therapeutics, Inc. | 526.42M | -3.64% | 139,204 | 88.24M |
| 223 | PROK | ProKidney Corp. | 519.37M | -1.71% | 634,345 | 893.00K |
| 224 | AVTX | Avalo Therapeutics, Inc. | 515.32M | -2.82% | 364,938 | 59.00K |
| 225 | NGNE | Neurogene Inc. | 514.67M | -0.15% | 55,075 | 925.00K |
| 226 | PRTA | Prothena Corporation plc | 505.99M | 0.68% | 117,381 | 57.94M |
| 227 | STTK | Shattuck Labs, Inc. | 503.37M | -1.33% | 92,318 | 1.00M |
| 228 | ASMB | Assembly Biosciences, Inc. | 489.49M | -2.90% | 17,211 | 71.10M |
| 229 | OCGN | Ocugen, Inc. | 487.46M | -2.04% | 2,181,995 | 4.47M |
| 230 | OVID | Ovid Therapeutics Inc. | 483.64M | -0.18% | 624,643 | 7.12M |
| 231 | FULC | Fulcrum Therapeutics, Inc. | 478.43M | -0.97% | 154,233 | 80.00M |
| 232 | UPB | Upstream Bio, Inc. | 470.19M | -7.69% | 176,834 | 3.32M |
| 233 | EPRX | Eupraxia Pharmaceuticals Inc. | 469.20M | -3.51% | 42,481 | - |
| 234 | ZURA | Zura Bio Limited | 462.54M | 1.56% | 55,096 | - |
| 235 | SGMT | Sagimet Biosciences Inc. | 457.27M | -2.57% | 170,011 | - |
| 236 | PRLD | Prelude Therapeutics Incorporated | 447.07M | -4.61% | 130,806 | 16.72M |
| 237 | LYEL | Lyell Immunopharma, Inc. | 446.82M | -0.47% | 13,491 | 31.00K |
| 238 | LXEO | Lexeo Therapeutics, Inc. | 443.65M | -1.91% | 146,107 | - |
| 239 | VTVT | vTv Therapeutics Inc. | 439.92M | 11.95% | 34,975 | 17.00K |
| 240 | ADCT | ADC Therapeutics SA | 437.49M | -1.16% | 306,143 | 79.18M |
| 241 | PRTC | PureTech Health plc | 432.38M | 2.91% | 3,050 | 4.66M |
| 242 | IPSC | Century Therapeutics, Inc. | 427.44M | 3.95% | 321,082 | 109.16M |
| 243 | VSTM | Verastem, Inc. | 420.91M | 1.48% | 699,205 | 49.59M |
| 244 | AUTL | Autolus Therapeutics plc | 409.86M | -9.94% | 2,142,417 | 75.39M |
| 245 | BNTC | Benitec Biopharma Inc. | 408.32M | 2.32% | 16,839 | - |
| 246 | REPL | Replimune Group, Inc. | 404.61M | -7.55% | 3,464,605 | - |
| 247 | ENTA | Enanta Pharmaceuticals, Inc. | 402.21M | -1.21% | 73,967 | 69.21M |
| 248 | CCCC | C4 Therapeutics, Inc. | 396.65M | -2.17% | 1,203,258 | 34.86M |
| 249 | LRMR | Larimar Therapeutics, Inc. | 396.31M | -6.95% | 2,073,498 | - |
| 250 | MNPR | Monopar Therapeutics Inc. | 395.29M | -3.96% | 185,231 | - |
| 251 | VNDA | Vanda Pharmaceuticals Inc. | 385.47M | -0.31% | 282,051 | 217.78M |
| 252 | XFOR | X4 Pharmaceuticals, Inc. | 384.82M | -3.55% | 107,091 | 9.01M |
| 253 | RCKT | Rocket Pharmaceuticals, Inc. | 375.08M | -4.58% | 980,344 | - |
| 254 | PBYI | Puma Biotechnology, Inc. | 365.97M | 0.28% | 30,469 | 227.18M |
| 255 | RZLT | Rezolute, Inc. | 364.59M | 4.80% | 482,353 | - |
| 256 | GLSI | Greenwich LifeSciences, Inc. | 362.99M | 3.56% | 46,672 | - |
| 257 | IRD | Opus Genetics, Inc. | 360.58M | 0.40% | 342,261 | 11.98M |
| 258 | CMPX | Compass Therapeutics, Inc. | 360.18M | 1.52% | 2,744,970 | 850.00K |
| 259 | YDES | YD Bio Limited | 351.60M | -3.85% | 3,933 | 510.36K |
| 260 | SRZN | Surrozen, Inc. | 349.54M | 0.96% | 6,633 | 7.49M |
| 261 | NMRA | Neumora Therapeutics, Inc. | 348.93M | 7.30% | 635,445 | - |
| 262 | AVIR | Atea Pharmaceuticals, Inc. | 348.12M | -4.81% | 352,153 | - |
| 263 | NVCT | Nuvectis Pharma, Inc. | 343.51M | 7.56% | 62,908 | - |
| 264 | IVVD | Invivyd, Inc. | 336.54M | -19.05% | 6,263,179 | 53.43M |
| 265 | DMAC | DiaMedica Therapeutics Inc. | 336.23M | -0.32% | 22,091 | - |
| 266 | RGNX | REGENXBIO Inc. | 336.03M | -35.16% | 6,651,347 | 87.82M |
| 267 | NAUT | Nautilus Biotechnology, Inc. | 335.49M | -10.51% | 464,498 | - |
| 268 | SLN | Silence Therapeutics plc | 330.64M | 0.29% | 14,016 | 839.00K |
| 269 | LCTX | Lineage Cell Therapeutics, Inc. | 330.27M | 3.50% | 867,790 | 14.78M |
| 270 | IMRX | Immuneering Corporation | 329.96M | -5.20% | 476,034 | - |
| 271 | BCYC | Bicycle Therapeutics plc | 328.67M | -0.53% | 168,008 | 63.50M |
| 272 | IKT | Inhibikase Therapeutics, Inc. | 317.84M | -1.84% | 132,812 | 1.00 |
| 273 | ABEO | Abeona Therapeutics Inc. | 316.32M | -2.80% | 763,780 | 14.54M |
| 274 | ACHV | Achieve Life Sciences, Inc. | 312.25M | -1.59% | 400,661 | - |
| 275 | PALI | Palisade Bio, Inc. | 308.06M | -1.60% | 557,582 | - |
| 276 | ARMP | Armata Pharmaceuticals, Inc. | 306.04M | -5.44% | 21,791 | 4.90M |
| 277 | OABI | OmniAb, Inc. | 304.44M | 4.48% | 276,226 | 28.94M |
| 278 | NGEN | NervGen Pharma Corp. | 304.28M | 3.29% | 51,945 | - |
| 279 | NAGE | Niagen Bioscience, Inc. | 301.69M | 0.53% | 308,052 | 130.42M |
| 280 | CLLS | Cellectis S.A. | 301.58M | -0.75% | 17,721 | 75.11M |
| 281 | ELDN | Eledon Pharmaceuticals, Inc. | 300.32M | 0.13% | 704,789 | - |
| 282 | FENC | Fennec Pharmaceuticals Inc. | 292.63M | 24.52% | 479,373 | 51.00M |
| 283 | TARA | Protara Therapeutics, Inc. | 288.33M | -1.35% | 193,042 | - |
| 284 | ZNTL | Zentalis Pharmaceuticals, Inc. | 286.17M | -6.07% | 781,241 | 26.87M |
| 285 | CGEN | Compugen Ltd. | 283.66M | 5.26% | 330,993 | 72.76M |
| 286 | EDIT | Editas Medicine, Inc. | 281.48M | -0.86% | 650,036 | 38.69M |
| 287 | AVXL | Anavex Life Sciences Corp. | 278.94M | -2.27% | 808,620 | - |
| 288 | ACIU | AC Immune SA | 276.77M | -1.76% | 161,796 | 4.62M |
| 289 | ALXO | ALX Oncology Holdings Inc. | 274.50M | 0.49% | 181,445 | - |
| 290 | SABS | SAB Biotherapeutics, Inc. | 271.97M | -2.27% | 429,879 | 114.70K |
| 291 | ARTV | Artiva Biotherapeutics, Inc. | 271.88M | 4.76% | 155,286 | 251.00K |
| 292 | MGNX | MacroGenics, Inc. | 266.63M | 21.59% | 1,976,178 | 157.08M |
| 293 | WHWK | Whitehawk Therapeutics, Inc. | 265.92M | 9.13% | 197,699 | 7.15M |
| 294 | VYGR | Voyager Therapeutics, Inc. | 261.62M | 4.34% | 437,385 | 36.49M |
| 295 | CHRS | Coherus Oncology, Inc. | 257.60M | -2.05% | 982,512 | 46.88M |
| 296 | HELP | Cybin Inc. | 256.68M | -0.97% | 196,276 | - |
| 297 | ALEC | Alector, Inc. | 251.47M | 5.35% | 238,031 | 18.42M |
| 298 | OBIO | Orchestra BioMed Holdings, Inc. | 247.31M | 1.72% | 165,060 | 32.72M |
| 299 | RNAC | Cartesian Therapeutics, Inc. | 245.04M | -0.95% | 30,171 | 1.78M |
| 300 | ADAG | Adagene Inc. | 243.81M | -0.27% | 685 | 7.67M |
| 301 | CDXS | Codexis, Inc. | 241.33M | 6.20% | 378,573 | 78.09M |
| 302 | FHTX | Foghorn Therapeutics Inc. | 240.14M | -1.92% | 21,376 | 28.22M |
| 303 | NERV | Minerva Neurosciences, Inc. | 239.38M | -1.62% | 15,394 | - |
| 304 | FATE | Fate Therapeutics, Inc. | 237.78M | -4.45% | 2,038,804 | 6.32M |
| 305 | LENZ | LENZ Therapeutics, Inc. | 236.73M | -6.21% | 291,882 | 20.99M |
| 306 | TRDA | Entrada Therapeutics, Inc. | 234.22M | -11.20% | 212,758 | 5.74M |
| 307 | HUMA | Humacyte, Inc. | 233.12M | -7.08% | 5,301,601 | 2.02M |
| 308 | NBP | NovaBridge Biosciences | 231.88M | -2.20% | 223,814 | - |
| 309 | CAMP | Camp4 Therapeutics Corporation | 229.51M | -1.78% | 17,900 | 3.93M |
| 310 | UNCY | Unicycive Therapeutics, Inc. | 229.35M | 0.94% | 281,678 | - |
| 311 | ARCT | Arcturus Therapeutics Holdings Inc. | 227.95M | -2.91% | 226,718 | 54.71M |
| 312 | TNXP | Tonix Pharmaceuticals Holding Corp. | 225.32M | 2.13% | 155,433 | 17.56M |
| 313 | SLGL | Sol-Gel Technologies Ltd. | 224.96M | -5.80% | 5,587 | 19.39M |
| 314 | CNTX | Context Therapeutics Inc. | 216.83M | - | 209,576 | - |
| 315 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 215.41M | -0.04% | 111,523 | - |
| 316 | CNTN | Canton Strategic Holdings, Inc. | 214.73M | 7.98% | 551,470 | - |
| 317 | CRBU | Caribou Biosciences, Inc. | 214.20M | 2.83% | 990,338 | 11.20M |
| 318 | MIST | Milestone Pharmaceuticals Inc. | 212.24M | -9.30% | 2,556,859 | 1.78M |
| 319 | DTIL | Precision BioSciences, Inc. | 212.10M | -1.44% | 79,996 | 45.07M |
| 320 | MDWD | MediWound Ltd. | 209.88M | 0.49% | 21,661 | 16.96M |
| 321 | NKTX | Nkarta, Inc. | 208.91M | -4.58% | 175,538 | - |
| 322 | KPTI | Karyopharm Therapeutics Inc. | 207.62M | 4.07% | 476,841 | 146.07M |
| 323 | KROS | Keros Therapeutics, Inc. | 206.98M | -12.76% | 262,153 | 33.18M |
| 324 | RNA | Atrium Therapeutics, Inc. | 206.97M | 0.30% | 29,875 | 18.62M |
| 325 | TNYA | Tenaya Therapeutics, Inc. | 206.15M | -0.99% | 2,879,065 | 225.00K |
| 326 | ELTX | Elicio Therapeutics, Inc. | 204.66M | -1.55% | 15,060 | - |
| 327 | ORMP | Oramed Pharmaceuticals Inc. | 188.07M | 1.97% | 54,882 | 2.00M |
| 328 | TLSA | Tiziana Life Sciences Ltd | 180.59M | -5.67% | 74,544 | - |
| 329 | IFRX | InflaRx N.V. | 177.84M | -2.38% | 933,562 | 33.82K |
| 330 | PRQR | ProQR Therapeutics N.V. | 176.48M | -1.47% | 195,927 | 15.73M |
| 331 | ENLV | Enlivex Ltd. | 176.01M | -0.30% | 89,586 | - |
| 332 | HRTX | Heron Therapeutics, Inc. | 175.50M | 1.40% | 766,547 | 150.71M |
| 333 | ABOS | Acumen Pharmaceuticals, Inc. | 174.43M | -3.01% | 115,487 | - |
| 334 | IMUX | Immunic, Inc. | 170.13M | -3.55% | 102,403 | - |
| 335 | ANTX | AN2 Therapeutics, Inc. | 168.82M | 8.82% | 109,964 | - |
| 336 | PLYX | Polaryx Therapeutics, Inc. | 166.17M | 4.31% | 91,370 | - |
| 337 | BDTX | Black Diamond Therapeutics, Inc. | 165.03M | 0.70% | 243,865 | 70.00M |
| 338 | KRRO | Korro Bio, Inc. | 161.24M | -0.18% | 19,046 | 3.84M |
| 339 | KZIA | Kazia Therapeutics Limited | 160.78M | 0.50% | 25,509 | 1.27M |
| 340 | PLX | Protalix BioTherapeutics, Inc. | 160.34M | 3.11% | 361,143 | 76.38M |
| 341 | HURA | TuHURA Biosciences, Inc. | 160.22M | 0.40% | 168,365 | - |
| 342 | MENS | Jyong Biotech Ltd. | 159.18M | 2.48% | 25,254 | - |
| 343 | GUTS | Fractyl Health, Inc. | 156.11M | 3.76% | 3,462,333 | 3.00K |
| 344 | GALT | Galectin Therapeutics Inc. | 155.35M | 5.83% | 116,602 | - |
| 345 | SPRB | Spruce Biosciences, Inc. | 154.18M | -0.86% | 11,572 | 697.00K |
| 346 | SPRO | Spero Therapeutics, Inc. | 149.96M | 6.15% | 1,035,789 | 61.19M |
| 347 | EQ | Equillium, Inc. | 149.85M | 2.60% | 96,311 | 4.39M |
| 348 | AGEN | Agenus Inc. | 145.38M | 0.86% | 176,629 | 123.87M |
| 349 | MOLN | Molecular Partners AG | 143.91M | -3.75% | 498 | 856.30K |
| 350 | CNTB | Connect Biopharma Holdings Limited | 140.46M | 1.43% | 60,158 | 233.00K |
| 351 | ALPS | Alps Group Inc | 139.76M | -0.02% | 5,784 | 3.74M |
| 352 | PYXS | Pyxis Oncology, Inc. | 138.91M | -15.65% | 804,488 | 13.86M |
| 353 | NTHI | NeOnc Technologies Holdings, Inc. | 138.54M | 1.48% | 20,888 | 39.99K |
| 354 | AARD | Aardvark Therapeutics, Inc. | 138.10M | -3.95% | 46,271 | - |
| 355 | OKUR | OnKure Therapeutics, Inc. | 137.34M | - | 29,952 | - |
| 356 | GNLX | Genelux Corporation | 135.45M | -4.39% | 159,126 | 8.00K |
| 357 | IPHA | Innate Pharma S.A. | 134.92M | 48.48% | 1,103,113 | 10.57M |
| 358 | EDSA | Edesa Biotech, Inc. | 132.22M | -2.36% | 79,368 | - |
| 359 | ACOG | Alpha Cognition Inc. | 122.15M | -5.71% | 22,093 | 10.22M |
| 360 | TTRX | Turn Therapeutics Inc. | 121.24M | 1.50% | 12,077 | - |
| 361 | KLRS | Kalaris Therapeutics, Inc. | 120.94M | 8.90% | 94,817 | - |
| 362 | VRCA | Verrica Pharmaceuticals Inc. | 119.39M | -5.70% | 28,442 | 37.16M |
| 363 | PEPG | PepGen Inc. | 116.90M | -5.06% | 575,775 | - |
| 364 | CRDF | Cardiff Oncology, Inc. | 115.55M | - | 197,266 | 593.00K |
| 365 | ENGN | enGene Therapeutics Inc. | 114.55M | 11.04% | 2,800,817 | - |
| 366 | COYA | Coya Therapeutics, Inc. | 113.06M | 6.17% | 78,641 | 7.94M |
| 367 | RANI | Rani Therapeutics Holdings, Inc. | 110.79M | 5.71% | 702,161 | 1.63M |
| 368 | INO | Inovio Pharmaceuticals, Inc. | 110.21M | 0.37% | 1,450,785 | 65.34K |
| 369 | CBUS | Cibus, Inc. | 109.47M | -1.37% | 114,498 | 3.64M |
| 370 | BMEA | Biomea Fusion, Inc. | 106.28M | -0.68% | 595,103 | - |
| 371 | CGTX | Cognition Therapeutics, Inc. | 106.24M | -0.92% | 644,299 | - |
| 372 | NRXP | NRx Pharmaceuticals, Inc. | 105.05M | 7.80% | 404,904 | 1.23M |
| 373 | QTTB | Q32 Bio Inc. | 104.11M | 3.37% | 51,265 | 53.74M |
| 374 | ALDX | Aldeyra Therapeutics, Inc. | 102.24M | -0.29% | 362,361 | - |
| 375 | VANI | Vivani Medical, Inc. | 101.76M | 1.72% | 222,110 | - |
| 376 | ONCY | Oncolytics Biotech Inc. | 101.01M | -0.14% | 397,434 | - |
| 377 | SEER | Seer, Inc. | 99.30M | -0.56% | 381,309 | 16.58M |
| 378 | LONA | LeonaBio, Inc. | 96.28M | -0.68% | 55,494 | - |
| 379 | ANIX | Anixa Biosciences, Inc. | 95.89M | -1.38% | 70,546 | - |
| 380 | PMN | ProMIS Neurosciences, Inc. | 95.51M | 0.76% | 11,924 | - |
| 381 | NRXS | NeurAxis, Inc. | 92.16M | 1.26% | 53,893 | 4.28M |
| 382 | PTHS | Pelthos Therapeutics Inc. | 90.40M | 3.58% | 33,633 | 16.80M |
| 383 | RNTX | Rein Therapeutics Inc. | 89.74M | -0.86% | 93,879 | - |
| 384 | CSBR | Champions Oncology, Inc. | 87.49M | 4.65% | 4,500 | 57.95M |
| 385 | ACRV | Acrivon Therapeutics, Inc. | 86.03M | 4.69% | 252,818 | - |
| 386 | CUE | Cue Biopharma, Inc. | 85.62M | -10.76% | 79,902 | 27.47M |
| 387 | ACET | Adicet Bio, Inc. | 85.27M | 0.62% | 73,980 | - |
| 388 | EXOZ | eXoZymes, Inc. | 84.96M | 1.42% | 2,612 | -700.00 |
| 389 | OKYO | OKYO Pharma Limited | 83.97M | -1.23% | 21,999 | - |
| 390 | PYPD | PolyPid Ltd. | 83.11M | 3.20% | 56,228 | - |
| 391 | ATHE | Alterity Therapeutics Limited | 82.93M | 1.30% | 25,192 | 4.43M |
| 392 | PDSB | PDS Biotechnology Corporation | 82.61M | 11.28% | 1,333,315 | - |
| 393 | ATRA | Atara Biotherapeutics, Inc. | 82.14M | -7.92% | 166,448 | 23.14M |
| 394 | OSTX | OS Therapies Incorporated | 81.55M | 8.38% | 992,363 | - |
| 395 | GOSS | Gossamer Bio, Inc. | 78.74M | -2.36% | 1,214,850 | 48.47M |
| 396 | MAIA | MAIA Biotechnology, Inc. | 78.57M | 0.39% | 124,054 | - |
| 397 | GANX | Gain Therapeutics, Inc. | 78.48M | 3.37% | 274,186 | - |
| 398 | XBIT | XBiotech Inc. | 78.05M | 2.40% | 2,635 | - |
| 399 | MCRB | Seres Therapeutics, Inc. | 76.38M | 2.19% | 11,941 | 1.15M |
| 400 | ICCC | ImmuCell Corporation | 75.81M | 0.24% | 17,007 | 27.64M |
| 401 | RLYB | Rallybio Corporation | 75.32M | -0.77% | 10,804 | 858.00K |
| 402 | ANVS | Annovis Bio, Inc. | 74.84M | -2.70% | 518,961 | - |
| 403 | FBIO | Fortress Biotech, Inc. | 73.75M | -0.45% | 262,766 | 63.26M |
| 404 | PLRX | Pliant Therapeutics, Inc. | 72.44M | - | 69,839 | - |
| 405 | PMVP | PMV Pharmaceuticals, Inc. | 70.13M | 1.94% | 324,816 | - |
| 406 | MNOV | MediciNova, Inc. | 69.16M | 2.55% | 16,444 | 409.66K |
| 407 | ACTU | Actuate Therapeutics, Inc. | 69.00M | -2.02% | 20,163 | - |
| 408 | TCRX | TScan Therapeutics, Inc. | 67.31M | -3.45% | 404,061 | 9.14M |
| 409 | IMA | ImageneBio, Inc. | 65.77M | 1.91% | 5,756 | 800.00K |
| 410 | IBO | Impact BioMedical Inc. | 64.24M | 2.41% | 12,887 | 39.00K |
| 411 | ENTX | Entera Bio Ltd. | 63.99M | 0.78% | 67,761 | 42.00K |
| 412 | HYFT | MindWalk Holdings Corp. | 63.08M | 0.79% | 21,037 | 20.70M |
| 413 | BYSI | BeyondSpring Inc. | 61.47M | 3.10% | 2,017 | 1.88M |
| 414 | DWTX | Dogwood Therapeutics, Inc. | 61.12M | -1.61% | 40,026 | - |
| 415 | IMMP | Immutep Limited | 59.94M | -1.46% | 294,237 | 5.28M |
| 416 | FLNA | Filana Therapeutics, Inc. | 58.94M | -0.81% | 159,503 | - |
| 417 | LIXT | Lixte Biotechnology Holdings, Inc. | 58.79M | 1.20% | 36,813 | - |
| 418 | KALA | KALA BIO, Inc. | 56.33M | -0.98% | 14,280 | - |
| 419 | INKT | MiNK Therapeutics, Inc. | 56.30M | 2.26% | 39,707 | - |
| 420 | CING | Cingulate Inc. | 55.74M | -7.52% | 575,645 | - |
| 421 | IBIO | iBio, Inc. | 55.12M | -1.61% | 305,742 | 300.00K |
| 422 | TIL | Instil Bio, Inc. | 54.66M | 0.50% | 13,525 | - |
| 423 | ATYR | aTyr Pharma, Inc. | 53.05M | 36.65% | 8,395,471 | 190.00K |
| 424 | HYPD | Hyperion DeFi, Inc. | 51.85M | 4.29% | 341,231 | 813.46K |
| 425 | MGX | Metagenomi Therapeutics, Inc. | 50.64M | -2.54% | 185,166 | 22.33M |
| 426 | ESLA | Estrella Immunopharma, Inc. | 49.84M | -2.66% | 25,041 | - |
| 427 | RADX | Radiopharm Theranostics Limited | 48.91M | 4.87% | 32,032 | 10.86M |
| 428 | XLO | Xilio Therapeutics, Inc. | 48.46M | 4.38% | 635,374 | 53.48M |
| 429 | INMB | INmune Bio Inc. | 44.93M | 15.75% | 3,383,684 | 50.00K |
| 430 | ATOS | Atossa Therapeutics, Inc. | 44.18M | -0.58% | 18,480 | - |
| 431 | LITS | Lite Strategy, Inc. | 43.45M | 1.27% | 50,993 | - |
| 432 | DARE | Daré Bioscience, Inc. | 43.10M | 4.23% | 284,514 | 1.03M |
| 433 | NTRB | Nutriband Inc. | 42.84M | 0.69% | 3,656 | 2.04M |
| 434 | TELO | Telomir Pharmaceuticals, Inc. | 42.63M | 0.81% | 50,869 | - |
| 435 | ALGS | Aligos Therapeutics, Inc. | 41.58M | 0.75% | 70,007 | 4.71M |
| 436 | ATNM | Actinium Pharmaceuticals, Inc. | 39.63M | -1.46% | 36,728 | 90.00K |
| 437 | MREO | Mereo BioPharma Group plc | 39.22M | -5.32% | 710,914 | 500.00K |
| 438 | RNXT | RenovoRx, Inc. | 38.82M | 1.53% | 69,934 | 1.12M |
| 439 | PSTV | Plus Therapeutics, Inc. | 38.70M | -1.05% | 92,951 | 5.21M |
| 440 | NXTC | NextCure, Inc. | 38.49M | 8.88% | 21,457 | - |
| 441 | TVRD | Tvardi Therapeutics, Inc. | 37.90M | 2.28% | 7,256 | - |
| 442 | TVGN | Tevogen Bio Holdings Inc. | 37.89M | 34.42% | 124,781 | - |
| 443 | NNVC | NanoViricides, Inc. | 36.93M | -0.58% | 124,428 | - |
| 444 | VERU | Veru Inc. | 36.59M | 0.88% | 5,239 | 16.89M |
| 445 | CRVO | CervoMed Inc. | 34.77M | 0.94% | 5,729 | 4.01M |
| 446 | PLUR | Pluri Inc. | 34.57M | -1.99% | 7,018 | 1.34M |
| 447 | EVAX | Evaxion A/S | 34.53M | -0.48% | 20,866 | 7.53M |
| 448 | BOLD | Boundless Bio, Inc. | 34.52M | - | 82,258 | - |
| 449 | SNTI | Senti Biosciences Holdings, Inc. | 33.95M | 13.19% | 290,831 | 22.00K |
| 450 | GRCE | Grace Therapeutics, Inc. | 33.89M | -2.67% | 213,910 | - |
| 451 | QNTM | Quantum BioPharma Ltd. | 32.55M | 20.48% | 539,233 | - |
| 452 | PTN | Palatin Technologies, Inc. | 32.25M | -4.83% | 18,380 | 12.88M |
| 453 | LTRN | Lantern Pharma Inc. | 32.06M | 13.94% | 487,243 | - |
| 454 | SKYE | Skye Bioscience, Inc. | 31.44M | 9.20% | 153,544 | - |
| 455 | NRSN | NeuroSense Therapeutics Ltd. | 30.95M | 5.15% | 62,409 | - |
| 456 | BCTX | BriaCell Therapeutics Corp. | 30.28M | 2.87% | 96,884 | - |
| 457 | APLM | Apollomics, Inc. | 30.24M | 1.79% | 11,650 | 8.84M |
| 458 | PLRZ | Polyrizon Ltd. | 29.95M | 5.40% | 51,399 | - |
| 459 | TPST | Tempest Therapeutics, Inc. | 29.84M | 13.04% | 111,747 | - |
| 460 | IGC | IGC Pharma, Inc. | 29.62M | 1.28% | 79,948 | 1.11M |
| 461 | BRNS | Barinthus Biotherapeutics plc | 28.59M | 2.93% | 8,817 | 14.97M |
| 462 | LSTA | Lisata Therapeutics, Inc. | 28.18M | -4.88% | 17,513 | 170.00K |
| 463 | KYNB | Kyntra Bio, Inc. | 28.18M | -0.57% | 5,770 | 7.44M |
| 464 | SNSE | Sensei Biotherapeutics, Inc. | 27.71M | -1.92% | 8,238 | - |
| 465 | NEUP | Neuphoria Therapeutics Inc. | 26.85M | - | 8,351 | 14.99M |
| 466 | HOWL | Werewolf Therapeutics, Inc. | 26.68M | -5.98% | 560,763 | 1.14M |
| 467 | DYAI | Dyadic International, Inc. | 26.59M | 2.72% | 11,678 | 3.09M |
| 468 | VTGN | Vistagen Therapeutics, Inc. | 26.59M | 2.35% | 231,295 | 789.00K |
| 469 | JSPR | Jasper Therapeutics, Inc. | 26.07M | 1.21% | 84,272 | - |
| 470 | ABVC | ABVC BioPharma, Inc. | 25.95M | -1.87% | 34,082 | 797.92K |
| 471 | MRKR | Marker Therapeutics, Inc. | 23.84M | - | 15,190 | 3.55M |
| 472 | OTLK | Outlook Therapeutics, Inc. | 23.84M | -0.91% | 2,033,271 | 205.70K |
| 473 | SER | Serina Therapeutics, Inc. | 23.84M | 2.56% | 25,698 | 130.00K |
| 474 | ALLR | Allarity Therapeutics, Inc. | 23.50M | -1.30% | 126,083 | 320.00K |
| 475 | CELU | Celularity Inc. | 23.07M | 1.70% | 111,217 | 26.55M |
| 476 | VYNE | VYNE Therapeutics Inc. | 22.36M | 0.16% | 64,164 | 570.00K |
| 477 | GRDX | GridAI Technologies Corp. | 22.13M | 3.48% | 157,534 | - |
| 478 | LGVN | Longeveron Inc. | 21.32M | -3.58% | 442,506 | 1.20M |
| 479 | AEON | AEON Biopharma, Inc. | 21.18M | -1.83% | 9,158 | - |
| 480 | CRIS | Curis, Inc. | 20.45M | 2.31% | 64,302 | 7.06M |
| 481 | XCUR | Exicure, Inc. | 19.89M | -0.64% | 3,852 | 500.00K |
| 482 | CTXR | Citius Pharmaceuticals, Inc. | 19.76M | 12.15% | 837,754 | 3.94M |
| 483 | KTTA | Pasithea Therapeutics Corp. | 19.70M | 0.64% | 37,377 | - |
| 484 | OSRH | OSR Holdings, Inc. | 19.58M | -4.12% | 655,787 | 2.63M |
| 485 | QNCX | Quince Therapeutics, Inc. | 19.56M | -1.64% | 304,836 | - |
| 486 | LPCN | Lipocine Inc. | 19.10M | 2.59% | 45,039 | 2.00M |
| 487 | ICU | SeaStar Medical Holding Corporation | 18.19M | -1.09% | 93,979 | 1.23M |
| 488 | NCEL | NewcelX Ltd. | 17.79M | 2.01% | 3,362 | - |
| 489 | COCP | Cocrystal Pharma, Inc. | 17.44M | -1.17% | 34,405 | - |
| 490 | PASG | Passage Bio, Inc. | 17.07M | -3.62% | 19,268 | - |
| 491 | CVKD | Cadrenal Therapeutics, Inc. | 16.55M | 1.22% | 32,401 | - |
| 492 | INAB | IN8bio, Inc. | 16.15M | 3.14% | 8,104 | - |
| 493 | TRAW | Traws Pharma, Inc. | 15.64M | -10.47% | 567,454 | 2.79M |
| 494 | LEXX | Lexaria Bioscience Corp. | 15.37M | 2.91% | 61,955 | 368.00K |
| 495 | TOVX | Theriva Biologics, Inc. | 14.72M | -2.82% | 1,078,525 | 300.00K |
| 496 | GNTA | Genenta Science S.p.A. | 14.43M | 4.21% | 50,303 | - |
| 497 | HIND | Vyome Holdings, Inc. | 13.62M | 1.04% | 29,529 | 152.72K |
| 498 | BLRX | BioLineRx Ltd. | 13.46M | 0.64% | 6,915 | 1.18M |
| 499 | CYCN | Cyclerion Therapeutics, Inc. | 13.27M | 0.32% | 28,852 | 1.99M |
| 500 | GTBP | GT Biopharma, Inc. | 13.22M | 33.99% | 7,888,184 | - |